iBio, Inc. - 10-Q Filing

iBio, Inc. reports Q3 2026 financial position featuring complex equity structures including Series G/H warrants and multiple At-Market agreements.

SEC EDGAR ·

Tickers: $IBIO

Read the full article at SEC EDGAR

More Regulatory news